Dr. Polakoff studies how to improve treatments for diseases related to the immune system and cancer. He has researched specific antibodies that can better target cancer-related proteins, which may lead to more effective cancer therapies. His work also includes modifying immune-regulating proteins to enhance safety and effectiveness in treating autoimmune diseases. Additionally, he investigates ways to improve healthcare management in settings like nursing homes, focusing on how to make treatments for conditions such as constipation and heart failure more effective for patients. Alongside clinical studies, he works on frameworks that ensure healthcare projects are sustainable and beneficial over time.
Key findings
In a study on antibody mutations, 67 out of over 1,000 mutations were identified that improved binding strength, which can enhance cancer treatments.
The optimized CTLA4-Ig protein variant showed a 17.5 times better binding rate to CD86, leading to improved inhibition of T cell activation.
A new heart failure management program increased ACE inhibitor use by 36% in one year and reduced hospitalizations for heart failure from 2.2 to 1.0 per 100 patients.
In assessing nursing home patients, 55% were diagnosed with constipation or used laxatives, indicating a need for better treatment protocols.
A specific test pattern identified 84% of Alzheimer's cases accurately, aiding in better diagnosis and treatment strategies.
Frequently asked questions
Does Dr. Polakoff study treatments for cancer?
Yes, he researches antibodies that target proteins involved in cancer, aiming to improve treatment effectiveness.
What conditions has Dr. Polakoff focused on in elderly patients?
He has worked on heart failure management and the assessment of constipation in long-term care patients.
Is Dr. Polakoff's work relevant to autoimmune diseases?
Yes, he studies proteins that regulate immune responses, which could enhance treatment safety and effectiveness for autoimmune conditions.
How does Dr. Polakoff ensure healthcare improvements are sustainable?
He developed a framework and checklist to guide healthcare projects, ensuring they can maintain their benefits over time.
What is the significance of Dr. Polakoff's research on dementia?
His work aids in accurately diagnosing Alzheimer's disease versus other types of dementia, leading to better treatment planning.
Publications in plain English
Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing.
2013
mAbs
Forsyth CM, Juan V, Akamatsu Y, DuBridge RB, Doan M +6 more
Plain English This study examined how different small changes (mutations) to a specific part of an antibody, which targets a protein involved in cell growth (epidermal growth factor receptor), affect its ability to bind to that protein. Researchers tested over 1,000 mutations and found 67 that made the antibody bind stronger. This matters because improving how well antibodies bind to their targets can enhance treatments for diseases like cancer.
Who this helps: Patients receiving antibody treatments, especially those with cancers related to the epidermal growth factor receptor.
Affinity and cross-reactivity engineering of CTLA4-Ig to modulate T cell costimulation.
2012
Journal of immunology (Baltimore, Md. : 1950)
Xu Z, Juan V, Ivanov A, Ma Z, Polakoff D +4 more
Plain English This study focused on modifying a protein called CTLA4-Ig to improve its ability to control immune responses by blocking signals that activate T cells. Researchers engineered variations of CTLA4-Ig and found that the best variant had a 17.5 times better binding rate to a molecule called CD86, leading to more effective inhibition of T cell activation compared to binding to another molecule, CD80. This research is important because optimizing this protein could enhance treatments for autoimmune diseases and improve patient safety and outcomes.
Who this helps: This helps patients with autoimmune diseases and their doctors.
Sustainability of partnership projects: a conceptual framework and checklist.
2007
Joint Commission journal on quality and patient safety
Edwards JC, Feldman PH, Sangl J, Polakoff D, Stern G +1 more
Plain English This study focused on improving healthcare by creating a framework and checklist to help ensure that quality and patient safety projects, known as Partnerships for Quality (PFQ), are sustainable over time. The researchers found that their developed framework, which highlights essential goals and necessary elements for sustainability, along with a checklist for early planning, were effective in guiding various projects. This work is important because it helps make sure that improvements in healthcare can continue to benefit patients and healthcare providers.
Who this helps: Patients and healthcare organizations.
Assessment of constipation management in long-term care patients.
2001
Journal of the American Medical Directors Association
Phillips C, Polakoff D, Maue SK, Mauch R
Plain English This study looked at how common constipation is in nursing home patients and how they are treated for it. Out of 712 patient records reviewed, 392 (55%) showed a diagnosis of constipation or use of laxatives, with about 28% diagnosed with constipation and 53.8% using laxatives regularly. Many patients on laxatives had other health issues that could cause constipation, and there was a lack of clear link between prescribed laxatives and proper documentation of constipation, indicating that treatment could be improved.
Who this helps: This research helps patients in nursing homes who suffer from constipation, as well as healthcare providers looking to improve their treatment strategies.
Collaborative partnership for optimizing heart failure outcomes in the long-term care environment: a clinical experience.
2000
Journal of the American Medical Directors Association
Polakoff D, Tuell K, Floyd K, Collette A, Wolfe M
Plain English This study focused on improving the treatment of heart failure, a serious condition affecting over 4.6 million Americans, especially in nursing homes. After implementing a new program aimed at better managing heart failure, researchers found that the use of a specific medication (ACE inhibitors) among patients increased by 36% in one year, and hospitalizations for heart failure dropped from 2.2 per 100 patients to 1.0 per 100 patients. This matters because better management of heart failure can lead to healthier patients and lower healthcare costs.
Who this helps: Patients living in long-term care facilities.
Neuropsychological test patterns in men for Alzheimer's and multi-infarct dementia.
1993
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
Russell EW, Polakoff D
Plain English This study looked at different ways to assess men's mental abilities to tell apart Alzheimer's Disease from multi-infarct dementia, which is caused by reduced blood flow to the brain. Researchers tested a group of 12 men with Alzheimer's and 13 men who had experienced mini-strokes. They found that a specific test pattern could accurately identify 84% of Alzheimer's cases and that another method correctly identified 92% of subjects overall. These findings are important because they can help doctors diagnose these conditions more accurately, leading to better treatment plans.
Who this helps: This helps patients and doctors by improving dementia diagnosis.
Veronica Juan Yoshiko Akamatsu Zhiyuan Ma Keith Wilson David B Powers Charles M Forsyth Robert B DuBridge Minhtam Doan Alexander V Ivanov Jennifer Razo
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.